top of page
Rinnit logo – modern health products and health news

What Is Autoimmune Autonomic Ganglionopathy? Symptoms, Causes, and Treatment

Oct 15
9 min read

Updated: 2 days ago

Medically reviewed by Dr. Baraa Alnahhal, MD · Last reviewed: October 2026

Quick Answer

Autoimmune autonomic ganglionopathy (AAG) is a rare disorder in which the immune system attacks the autonomic ganglia, disrupting involuntary functions such as blood pressure, heart rate and digestion. [1] It affects roughly 100 people per year in the United States. [1] Diagnosis includes autonomic tests and an antibody blood test. [1] [2] It is not curable, but most people manage symptoms successfully. [1]

Key Takeaways

  • AAG is extremely rare — about 100 new U.S. cases per year — and occurs when the immune system attacks the autonomic nervous system. [1]

  • The attack targets receptors in the autonomic ganglia, so automatic functions like blood pressure regulation stop working properly. [1]

  • Around half to two-thirds of people with AAG have high g-AChR antibody levels; these may correlate with how severe symptoms are. [1] [2] [6]

  • Hallmark symptoms include fainting, blood pressure drops on standing, dry eyes/mouth, constipation, dilated pupils, and urinary retention. [1]

  • There is no cure or standardized treatment, but plasmapheresis, IVIG, corticosteroids, and immunosuppressants help many, and about 1 in 3 improve without treatment. [1] [2]

What the research says

  • AAG is an antibody-mediated disease. Because AAG is so rare, the published evidence is mostly clinical reviews and single-patient reports rather than large trials. A clinical review explains that ganglionic AChR antibodies recognize the alpha3 subunit of the ganglionic receptor, inhibit receptor currents and impair transmission in autonomic ganglia. Patients with high antibody levels typically present with rapid-onset severe autonomic failure — orthostatic hypotension, gastrointestinal dysmotility, anhidrosis, bladder dysfunction and dry eyes and mouth — and a rabbit model reproduces the disease. (Vernino et al., Auton Neurosci, 2009) [5]

  • Combined immune therapy can help when one treatment is not enough. In a case report of a 68-year-old man with antibody-positive AAG, symptomatic drugs (midodrine, fludrocortisone and atomoxetine) did not work; immunoadsorption produced a noticeable improvement, and a follow-up course of rituximab led to a significant improvement in symptoms. This is a single case, not a trial. (Angeloudi et al., World J Methodol, 2025) [6]

  • Relapses can happen, and long-term treatment may be needed. In a reported case of antibody-positive AAG, the patient improved on methylprednisolone pulses and low-dose prednisone but relapsed after stopping prednisone. Repeated plasma exchange then helped, and low-dose prednisone plus mycophenolate mofetil gave significant improvement over long-term follow-up. The authors advise slow, cautious withdrawal of immunosuppressants. This is also a single case. (Lu et al., Front Neurol, 2025) [7]

What is autoimmune autonomic ganglionopathy? A person feeling dizzy while standing, a diagram of autonomic ganglia being attacked by antibodies, and the autonomic nervous system pathways reaching the heart, stomach, and bladder – rinnit.com
AAG attacks the body's autopilot: the nervous system that controls functions you never have to think about.

What is autoimmune autonomic ganglionopathy?

Autoimmune autonomic ganglionopathy (AAG) is an autoimmune disease where your immune system attacks your autonomic nervous system by mistake. [1] The autonomic nervous system is part of the peripheral nervous system, and it controls involuntary body processes such as breathing, blood pressure, and heart rate. [1]

AAG is a type of autonomic neuropathy, also grouped under the broader term dysautonomia — disorders of the autonomic nervous system. [1] Think of it as the body's autopilot malfunctioning: functions you never consciously control begin to misbehave.

How rare is autoimmune autonomic ganglionopathy?

AAG is extremely rare. In the United States, doctors diagnose about 100 people with AAG each year. [1] Because it is so uncommon, many people — and even some healthcare providers — have never heard of it, which is one reason diagnosis can take time.

How does AAG affect the body?

In AAG, the immune system damages a specific receptor in the autonomic ganglia. [1] [2] The autonomic ganglia are clusters of nerve cells distributed throughout the autonomic nervous system. These nerve cell clusters send and receive signals that control reflexes and other involuntary body functions — from your heartbeat to the way your other organs work. [1]

When the receptors in these ganglia are damaged, the body cannot process its own signals correctly. As a result, automatic body functions such as blood pressure regulation may not work properly. [1]

Six symptoms of autoimmune autonomic ganglionopathy: constipation, dilated pupils, dry mouth and eyes, fainting, low blood pressure on standing, and urinary retention – rinnit.com
Six ways AAG shows up: from fainting spells to dry eyes, each reflecting a disrupted involuntary function.

What are the symptoms of autoimmune autonomic ganglionopathy?

Symptoms of AAG can vary from person to person, but the most common ones reflect the breakdown of automatic functions:

Symptom

What it means

Fainting (syncope)

Losing consciousness, often related to blood pressure drops

Low blood pressure when standing (neurogenic orthostatic hypotension)

Blood pressure falls when moving to a standing position, causing dizziness

Dry mouth or dry eyes

Reduced automatic fluid production

Constipation

Slowed involuntary digestive activity

Dilated pupils (Adie's pupils)

Pupils fail to respond normally to light

Urinary retention

The bladder cannot empty automatically

You may not experience every symptom — the pattern varies depending on which signals are most affected.

The antibody connection: what are g-AChR antibodies?

About half to two-thirds of people with AAG have high levels of antibodies called ganglionic acetylcholine receptor antibodies (g-AChR antibodies). [1] [2] [6] Researchers believe that g-AChR antibody levels may correlate with how severe a person's symptoms are — in other words, higher levels tend to appear alongside more severe symptoms. [1]

This antibody finding matters for diagnosis too, and it has an important caution attached to it:

A g-AChR antibody blood test is not the same as an AChR antibody test, which is used to check for myasthenia gravis — a different neuromuscular condition. [1]

What causes autoimmune autonomic ganglionopathy?

Experts do not know exactly what causes AAG. [1] However, the patterns observed point to the immune system being triggered by something:

Possible cause

Description

Prior illness or infection

About 3 in 5 people with AAG develop it after another illness or infection

Paraneoplastic AAG

In some cases, the immune system produces certain antibodies in response to cancer, and those antibodies then attack the autonomic nervous system

Unknown (idiopathic)

In remaining cases, no clear trigger is identified

How is autoimmune autonomic ganglionopathy diagnosed?

To diagnose AAG, a healthcare provider will ask detailed questions about symptoms and perform a clinical exam. Because the condition affects many body systems, providers typically order a panel of tests that check how the autonomic nervous system is functioning:

Test

What it checks

Tilt table test

Heart rate and blood pressure when changing positions

Quantitative sudomotor axon reflex test (QSART)

How the sweat glands work

Thermoregulatory sweat test

The cause of decreased or increased sweating

Gastrointestinal tests (e.g., gastric emptying)

How digestion is functioning

Urinalysis

Bladder function

g-AChR antibody blood test

Antibody levels that may point to AAG

What treatment options are available?

AAG is so rare that there is no standardized treatment for it. [1] Instead, treatment plans typically focus on symptom management, and providers may combine several approaches:

Treatment

How it works

Plasma exchange (plasmapheresis)

Blood is drawn out, harmful cells are removed from the plasma, and the blood is returned to the body

Intravenous immunoglobulin (IVIG) therapy

The body receives extra immunoglobulin — a disease-fighting part of plasma

Intravenous corticosteroids

High doses of inflammation-reducing steroids (such as methylprednisolone or hydrocortisone) delivered through an IV

Immunosuppressive medications

Drugs such as rituximab that reduce the immune system's effects on healthy body systems

Treatment options for autoimmune autonomic ganglionopathy: plasma exchange, IVIG therapy, intravenous corticosteroids, and supportive lifestyle care – rinnit.com
Four pillars of AAG care: removing harmful antibodies, replenishing defenses, reducing inflammation, and supporting overall well-being.

Is autoimmune autonomic ganglionopathy curable?

AAG is not curable at this time. [1] However, many people successfully manage symptoms long-term. Notably, for about 1 in 3 people, AAG symptoms improve without treatment — though most people do deal with some symptoms for the rest of their lives. [1] [2]

What lifestyle choices support well-being with AAG?

There is no guaranteed way to prevent AAG, although some factors — such as a cancer diagnosis — may increase risk. [1] For people living with dysautonomia, providers often suggest healthy lifestyle choices to support overall well-being and help regulate blood pressure: [1]

Lifestyle choice

Why it helps

Aerobic exercise

Supports cardiovascular health and circulation

High-fluid, high-salt diet

Helps regulate blood pressure in dysautonomia

Stress management

Exercise, talking with a friend, or journaling to reduce stress

Quality sleep

Seven to eight hours nightly supports recovery and regulation

Compression garments

Increase circulation and reduce swelling

What other conditions are associated with autonomic neuropathy?

AAG is unique because it is both an autoimmune condition and a type of autonomic neuropathy. Several other autoimmune conditions can increase the chances of developing dysautonomia: [1]

Autoimmune condition

Type

Celiac disease

Digestive autoimmune condition

Guillain-Barré syndrome

Peripheral nerve disorder

Lupus (systemic lupus erythematosus)

Systemic autoimmune disease

Rheumatoid arthritis

Joint-targeting autoimmune disease

Sjögren's syndrome

Gland-targeting autoimmune disease

When should I see my healthcare provider?

See a healthcare provider if you are experiencing repeated fainting, unusual dizziness when standing, or a cluster of unexplained involuntary-function problems — especially dry eyes, dry mouth, constipation, or bladder difficulty. These symptoms can have many causes, but because AAG is rare and treatable, it deserves proper evaluation.

Useful questions to bring to an appointment:

Question

Why it matters

What is the most likely cause of my symptoms?

Rules in or out autonomic causes

What tests do I need to diagnose AAG?

Clarifies the testing plan

What are the treatment options?

Sets expectations for symptom management

What are the chances my symptoms improve without treatment?

Grounds prognosis in realistic odds

What lifestyle changes should I make?

Supports blood pressure and overall health

Conclusion

Autoimmune autonomic ganglionopathy is a rare but real disorder in which the immune system attacks the body's own autopilot — the autonomic ganglia that regulate blood pressure, heart rate, digestion, and more. [1] Its hallmark signs — fainting on standing, dry eyes and mouth, and bladder or digestive disruption — are easy to overlook or misattribute, which makes careful autonomic testing and g-AChR antibody screening essential.

While there is no cure, there is genuine reason for hope: most people manage their symptoms long-term, about one in three improve without treatment, and a growing set of immune-targeted therapies exists for those who need them. [1] [2] If your body's involuntary functions have started acting strangely, it is worth raising the possibility with a healthcare provider.

Want to turn complex medical topics like this one into clear, shareable visuals? Rinnit's infographic templates make it easy to present rare-disease knowledge in a way patients and families can actually understand.

Frequently Asked Questions

What is autoimmune autonomic ganglionopathy?

AAG is a rare autoimmune disease in which the immune system mistakenly attacks the autonomic nervous system — the network that controls involuntary functions like heart rate, blood pressure, and digestion. [1]

How rare is AAG?

Extremely rare. About 100 people are diagnosed with AAG each year in the United States. [1]

What causes autoimmune autonomic ganglionopathy?

The exact cause is unknown. About 3 in 5 people develop AAG after another illness or infection, and in some cases it is paraneoplastic — triggered when the immune system makes antibodies in response to cancer that then attack the autonomic nervous system. [1]

What are the main symptoms?

Fainting (syncope), low blood pressure when standing (neurogenic orthostatic hypotension), dry mouth or dry eyes, constipation, dilated pupils (Adie's pupils), and urinary retention. [1]

What are g-AChR antibodies?

Ganglionic acetylcholine receptor (g-AChR) antibodies are found at high levels in about half to two-thirds of people with AAG. [1] [2] [6] Researchers believe these levels correlate with symptom severity, and the blood test helps point toward an AAG diagnosis. [1] [2]

Is the g-AChR antibody test the same as an AChR antibody test?

No. The g-AChR test is used for AAG. An AChR antibody test checks for myasthenia gravis, a different neuromuscular condition. [1]

How is AAG diagnosed?

Through symptom questions, a clinical exam, autonomic function tests (tilt table test, QSART sweat testing, thermoregulatory sweat test, gastric emptying, urinalysis), and a g-AChR antibody blood test. [1] [2]

Is there a cure for AAG?

No. AAG is not currently curable, but many people successfully manage their symptoms long-term, and about 1 in 3 improve without treatment. [1] [2]

How is AAG treated?

Because it is so rare, there is no standardized treatment. Providers usually combine symptom-management approaches: plasma exchange (plasmapheresis), IVIG therapy, intravenous corticosteroids, and immunosuppressive medications such as rituximab. [1] [2]

What lifestyle changes help with dysautonomia?

Aerobic exercise, a high-fluid and high-salt diet to regulate blood pressure, stress management, seven to eight hours of nightly sleep, and compression garments for circulation. [1]

Which autoimmune conditions raise the risk of dysautonomia?

Celiac disease, Guillain-Barré syndrome, lupus, rheumatoid arthritis, and Sjögren's syndrome can all increase the chances of developing dysautonomia. [1]

Can AAG be prevented?

There is no guaranteed way to prevent AAG. A cancer diagnosis may increase risk, [1] but adopting healthy lifestyle choices supports overall well-being.

Related Reading

References

  1. Cleveland Clinic. Autoimmune autonomic ganglionopathy. Cleveland Clinic. Last updated April 18, 2022. https://my.clevelandclinic.org/health/diseases/22781-autoimmune-autonomic-ganglionopathy

  2. Dysautonomia International. Autoimmune Autonomic Ganglionopathy Summary. Dysautonomia International. Accessed October 30, 2026. http://www.dysautonomiainternational.org/page.php?ID=124

  3. Genetic and Rare Diseases Information Center (GARD). Autoimmune autonomic ganglionopathy. National Center for Advancing Translational Sciences. Last updated February 2024 (archived March 17, 2024). https://web.archive.org/web/20240317104221/https://rarediseases.info.nih.gov/diseases/11917/autoimmune-autonomic-ganglionopathy

  4. National Institute of Diabetes and Digestive and Kidney Diseases. Autonomic neuropathy. NIDDK. Last reviewed February 2018. https://www.niddk.nih.gov/health-information/diabetes/overview/preventing-problems/nerve-damage-diabetic-neuropathies/autonomic-neuropathy

  5. Vernino S, Hopkins S, Wang Z. Autonomic ganglia, acetylcholine receptor antibodies, and autoimmune ganglionopathy. Auton Neurosci. 2009;146(1-2):3-7. PMID 18951069. https://doi.org/10.1016/j.autneu.2008.09.005

  6. Angeloudi E, Xanthopoulou M, Lima M, et al. Need for combined therapy for a rare case of autoimmune autonomic ganglionopathy: a case report. World J Methodol. 2025;15(4):101459. PMID 40900869. https://doi.org/10.5662/wjm.v15.i4.101459

  7. Lu Z, Cao X, Wang M, et al. A case of relapsed gAChR-positive autoimmune autonomic ganglionopathy treated by plasma exchange and mycophenolate mofetil. Front Neurol. 2025;15:1533840. PMID 39866515. https://doi.org/10.3389/fneur.2024.1533840

Medical disclaimer

This article is for general educational purposes only and does not replace professional medical advice, diagnosis, or treatment. Always consult a qualified healthcare provider with questions about your health.

Comments


bottom of page